Shares of Anterix Inc. (NASDAQ:ATEX) shot up 3.5% during mid-day trading on Monday . The company traded as high as $57.79 and last traded at $57.16. 2,456 shares changed hands during trading, a decline of 98% from the average session volume of 150,632 shares. The stock had previously closed at $55.25.
ATEX has been the subject of several research reports. JPMorgan Chase & Co. lifted their price objective on Anterix from $50.00 to $60.00 and gave the stock an “overweight” rating in a research report on Thursday, June 17th. Morgan Stanley boosted their price target on Anterix from $51.00 to $65.00 and gave the company an “equal weight” rating in a report on Wednesday, August 4th. Finally, B. Riley reiterated a “buy” rating on shares of Anterix in a report on Wednesday, June 9th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Anterix has a consensus rating of “Hold” and an average target price of $62.50.
The company’s 50 day moving average price is $58.55 and its 200-day moving average price is $52.83. The company has a market capitalization of $1.02 billion, a PE ratio of -18.92 and a beta of 0.46.
In other Anterix news, Director Leslie B. Daniels purchased 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 18th. The stock was purchased at an average cost of $55.35 per share, with a total value of $55,350.00. Following the transaction, the director now owns 32,906 shares in the company, valued at $1,821,347.10. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gena L. Ashe sold 2,301 shares of the company’s stock in a transaction on Friday, August 13th. The stock was sold at an average price of $56.11, for a total transaction of $129,109.11. Following the sale, the insider now directly owns 35,565 shares of the company’s stock, valued at $1,995,552.15. The disclosure for this sale can be found here. Over the last three months, insiders have bought 2,800 shares of company stock valued at $156,779 and have sold 34,701 shares valued at $1,971,133. 4.05% of the stock is owned by insiders.
Several institutional investors have recently modified their holdings of ATEX. Advisor Group Holdings Inc. acquired a new stake in shares of Anterix in the 2nd quarter valued at about $33,000. Nisa Investment Advisors LLC raised its stake in Anterix by 290.9% during the second quarter. Nisa Investment Advisors LLC now owns 1,075 shares of the company’s stock worth $64,000 after acquiring an additional 800 shares during the period. Emerald Advisers LLC acquired a new stake in Anterix during the second quarter worth about $66,000. Metropolitan Life Insurance Co NY raised its stake in Anterix by 74,875.0% during the second quarter. Metropolitan Life Insurance Co NY now owns 2,999 shares of the company’s stock worth $180,000 after acquiring an additional 2,995 shares during the period. Finally, Paloma Partners Management Co acquired a new stake in Anterix during the second quarter worth about $203,000. Institutional investors and hedge funds own 83.95% of the company’s stock.
Anterix Company Profile (NASDAQ:ATEX)
Anterix, Inc operates as a wireless communications company. The firm focuses on commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks, technologies and solutions. It’s solutions include Private LTE and Active Ecosystem. The company was founded by Peter Joel Lasensky and Richard Edward Rohmann in 1997 and is headquartered in Woodland Park, NJ.
See Also: Stock Portfolio Tracker
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.